Journal Article

DKFZ-2024-01183

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png Late-onset NPM1 mutation in a MYC-amplified relapsed / refractory acute myeloid leukemia patient treated with gemtuzumab ozogamicin and glasdegib.

Jaramillo, S. ; Scherer, M. ; Szu-Tu, C. ; Beneyto-Calabuig, S. ; Müller-Tidow, C. ; Schlenk, R. F.DKFZ* ; Hundemer, M. ; Velten, L. ; Pabst, C.

2024
Ferrata Storti Foundation Pavia

This record in other databases:  

Please use a persistent id in citations: doi:10.3324/haematol.2023.284922

Abstract: Not available.

Note: 2024 Nov 1;109(11):3811-3815

---

Contributing Institute(s):

1. Klinische Studienzentrale (W010)

Research Program(s):

1. 311 - Zellbiologie und Tumorbiologie (POF4-311) (POF4-311)

Appears in the scientific report 2024

---

Database coverage:
; ; Article Processing Charges ; BIOSIS Previews ; Biological Abstracts ; Clarivate Analytics Master Journal List ; Current Contents - Clinical Medicine ; Current Contents - Life Sciences ; DOAJ Seal ; Essential Science Indicators ; Fees ; PubMed Central ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection

---